These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3979839)

  • 1. Calculation of the permeability of the blood-retinal barrier to fluorescein.
    Lund-Andersen H; Krogsaa B; Larsen J
    Graefes Arch Clin Exp Ophthalmol; 1985; 222(4-5):173-6. PubMed ID: 3979839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of the permeability of the blood-retinal barrier in normal individuals.
    Oguro Y; Tsukahara Y; Saito I; Kondo T
    Invest Ophthalmol Vis Sci; 1985 Jul; 26(7):969-76. PubMed ID: 4008211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative vitreous fluorophotometry applying a mathematical model of the eye.
    Lund-Andersen H; Krogsaa B; la Cour M; Larsen J
    Invest Ophthalmol Vis Sci; 1985 May; 26(5):698-710. PubMed ID: 3997419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of blood-retinal barrier permeability: a reproducibility study in normal eyes.
    Chahal PS; Chowienczyk PJ; Kohner EM
    Invest Ophthalmol Vis Sci; 1985 Jul; 26(7):977-82. PubMed ID: 4008212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental retinal detachment. VI. The permeability of the blood-retinal barrier.
    Cantrill HL; Pederson JE
    Arch Ophthalmol; 1984 May; 102(5):747-51. PubMed ID: 6721768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorescein transport across the human blood-retina barrier in the direction vitreous to blood. Quantitative assessment in vivo.
    Engler CB; Sander B; Larsen M; Dalgaard P; Lund-Andersen H
    Acta Ophthalmol (Copenh); 1994 Dec; 72(6):655-62. PubMed ID: 7747570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transport of fluorescein in the ocular posterior segment in retinitis pigmentosa.
    Mallick KS; Zeimer RC; Fishman GA; Blair NP; Anderson RJ
    Arch Ophthalmol; 1984 May; 102(5):691-6. PubMed ID: 6721754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The blood-retinal barrier permeability in diabetic patients.
    Krogsaa B; Lund-Andersen H; Mehlsen J; Sestoft L; Larsen J
    Acta Ophthalmol (Copenh); 1981 Oct; 59(5):689-94. PubMed ID: 7315223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescein and fluorescein glucuronide in the vitreous body of diabetic patients.
    Lund-Andersen H; Larsen M; Dalgaard P; Olsen W
    Graefes Arch Clin Exp Ophthalmol; 1987; 225(3):173-6. PubMed ID: 3609757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping retinal fluorescein leakage with confocal scanning laser fluorometry of the human vitreous.
    Lobo CL; Bernardes RC; Santos FJ; Cunha-Vaz JG
    Arch Ophthalmol; 1999 May; 117(5):631-7. PubMed ID: 10326960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outward transport of fluorescein from the vitreous in normal human subjects.
    Blair NP; Zeimer RC; Rusin MM; Cunha-Vaz JG
    Arch Ophthalmol; 1983 Jul; 101(7):1117-21. PubMed ID: 6870634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barriers to fluorescein and protein movement.
    Marmor MF
    Jpn J Ophthalmol; 1985; 29(2):131-8. PubMed ID: 2413231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimation of permeability in blood-retinal barrier.
    Kojima M; Yoshida A; Ishiko S; Tanaka K
    Hokkaido Igaku Zasshi; 1990 Jul; 65(4):419-27. PubMed ID: 2227794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystalline retinopathy: evaluation of blood-retinal barrier by vitreous fluorophotometry.
    Yoshida A; Nara Y; Takahashi M
    Jpn J Ophthalmol; 1985; 29(3):290-300. PubMed ID: 4079126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The active transport of fluorescein by the retinal vessels and the retina.
    Cunha-Vaz JG; Maurice DM
    J Physiol; 1967 Aug; 191(3):467-86. PubMed ID: 4963870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration of the blood-retinal barrier and vitreous in sickle cell retinopathy.
    Paylor RR; Carney MD; Ogura Y; Cunha-Vaz JG; Jampol LM; Goldberg MF
    Int Ophthalmol; 1986 May; 9(2-3):103-8. PubMed ID: 3721713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of fluorescein in the vitreous.
    Palestine AG; Brubaker RF
    Invest Ophthalmol Vis Sci; 1981 Oct; 21(4):542-9. PubMed ID: 7287343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of fluorescein to vitreous in vitro.
    Knudsen LL
    Acta Ophthalmol (Copenh); 1987 Jun; 65(3):352-7. PubMed ID: 3618161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probenecid inhibition of the outward transport of fluorescein across the human blood-retina barrier.
    Engler CB; Sander B; Larsen M; Koefoed P; Parving HH; Lund-Andersen H
    Acta Ophthalmol (Copenh); 1994 Dec; 72(6):663-7. PubMed ID: 7747571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitreous fluorophotometry in rats with streptozocin-induced diabetes.
    Vine AK; Kisly AM; Betz AL; Howatt WF
    Arch Ophthalmol; 1984 Jul; 102(7):1083-5. PubMed ID: 6743087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.